Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
11626
PUT
DELISTED
Esperion Therapeutics
ESPR
| $51.9K | ﹤0.01% |
53,000
-79,900
| -60% | -$116K |
|
11627
PUT
Immunocore
IMCR
$1.76B
| $51.9K | ﹤0.01% |
+1,000
| New | +$59.2K |
|
|
UXIN
11628
PUT
Uxin Ltd
UXIN
$260M
| $51.8K | ﹤0.01% |
3,180
+2,200
| +224% | +$35.8K |
|
|
SQNS
11629
Sequans Communications SA
SQNS
$45.3M
| $51.8K | ﹤0.01% |
733
-1,220
| -62% | -$79.8K |
|
11630
PUT
Geospace Technologies
GEOS
$72.4M
| $51.8K | ﹤0.01% |
4,000
-24,000
| -86% | -$226K |
|
|
ENG
11631
DELISTED
ENGlobal Corp
ENG
| $51.7K | ﹤0.01% |
19,095
-13,138
| -41% | -$36.5K |
|
11632
PUT
BlackRock TCP Capital
TCPC
$342M
| $51.7K | ﹤0.01% |
4,400
-1,000
| -19% | -$12K |
|
11633
Alector
ALEC
$219M
| $51.6K | ﹤0.01% |
7,960
-213,191
| -96% | -$1.38M |
|
|
STKL
11634
CALL
DELISTED
SunOpta
STKL
| $51.6K | ﹤0.01% |
15,300
-45,100
| -75% | -$226K |
|
11635
Goldgroup Mining
GORO
$207M
| $51.5K | ﹤0.01% |
+120,441
| New | +$64.4K |
|
11636
PUT
Playboy Inc
PLBY
$151M
| $51.5K | ﹤0.01% |
64,300
+43,600
| +211% | +$62.6K |
|
|
AGEN
11637
Agenus
AGEN
$329M
| $51.5K | ﹤0.01% |
2,279
-301,573
| -99% | -$8.55M |
|
11638
Data I/O
DAIO
$32.9M
| $51.4K | ﹤0.01% |
13,499
-9,258
| -41% | -$37.5K |
|
11639
PUT
Descartes Systems
DSGX
$6.62B
| $51.4K | ﹤0.01% |
700
-31,300
| -98% | -$2.36M |
|
11640
CALL
VistaGen Therapeutics
VTGN
$11.9M
| $51.4K | ﹤0.01% |
+9,800
| New | +$43.5K |
|
11641
PUT
Cytek Biosciences
CTKB
$610M
| $51.3K | ﹤0.01% |
9,300
+5,700
| +158% | +$45.7K |
|
11642
CALL
Avantis US Equity ETF
AVUS
$14.5B
| $51.3K | ﹤0.01% |
700
+400
| +133% | +$30.4K |
|
|
ARC
11643
CALL
DELISTED
ARC Document Solutions, Inc.
ARC
| $51.2K | ﹤0.01% |
16,100
-21,200
| -57% | -$71.9K |
|
11644
PUT
Credicorp
BAP
$30.7B
| $51.2K | ﹤0.01% |
400
-600
| -60% | -$87.1K |
|
|
PRPH
11645
CALL
DELISTED
ProPhase Labs
PRPH
| $51.1K | ﹤0.01% |
1,170
-260
| -18% | -$15.2K |
|
11646
CALL
Acco Brands
ACCO
$401M
| $51.1K | ﹤0.01% |
8,900
-19,000
| -68% | -$106K |
|
|
PROF
11647
PUT
Profound Medical
PROF
$241M
| $51K | ﹤0.01% |
5,000
-3,300
| -40% | -$34.2K |
|
11648
PUT
Enel Chile
ENIC
$6.27B
| $50.9K | ﹤0.01% |
17,200
-2,000
| -10% | -$6.57K |
|
11649
CALL
Envela
ELA
$416M
| $50.7K | ﹤0.01% |
10,700
+2,500
| +30% | +$15.1K |
|
|
AHT
11650
PUT
Ashford Hospitality Trust
AHT
$20.8M
| $50.7K | ﹤0.01% |
2,120
-3,360
| -61% | -$107K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.